EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mechanism‐driven strategies for prevention of rheumatoid arthritis

V Michael Holers, Kristine A Kuhn, M Kristen Demoruelle, Jill M Norris, Gary S Firestein, Eddie A James, William H Robinson, Jane H Buckner, Kevin D Deane

Rheumatology & Autoimmunity · 2022-09 · 2 (3) · 109-119

DOI: 10.1002/rai2.12043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology & Autoimmunity, online erschienen am 15.06.2022. Verfasst von V Michael Holers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In seropositive rheumatoid arthritis (RA), the onset of clinically apparent inflammatory arthritis (IA) is typically preceded by a prolonged period of autoimmunity manifest by the presence of circulating autoantibodies that can include antibodies to citrullinated protein antigens (ACPA) and rheumatoid factor. This period before clinical IA can be designated preclinical RA in those individuals who have progressed to a clinical diagnosis of RA, and an “at‐risk” status in those who have not developed IA but exhibit predictive biomarkers of future clinical RA. With the goal of developing RA prevention strategies, studies have characterized immune phenotypes of preclinical RA/at‐risk states. From these studies, a model has emerged wherein mucosal inflammation and dysbiosis may lead first to local autoantibody production, which should normally be transient, but instead is followed by a systemic spread of the autoimmunity as manifested by serum autoantibody elevations, ultimately driving the development of clinically identified joint inflammation. This model can be envisioned as the progression of disease development through serial “checkpoints” that in principle should constrain or resolve autoimmunity; however, instead, the checkpoints “fail” and clinical RA develops. Herein we review the immune processes that are likely to be present at each step and the potential therapeutic strategies that could be envisioned to delay, diminish, halt, or even reverse the progression to clinical RA. Notably, these prevention strategies could utilize existing therapies approved for clinical RA, therapies approved for other diseases that target relevant pathways in the preclinical/at‐risk state, or approaches that target novel pathways.

Schlagwörter

Stichwörter der Autor:innen

Autoimmune diseaseInflammationMucosaPreventionRheumatoid arthritis

Autor:innen und Institutionen

  • Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Department of Epidemiology, Colorado School of Public Health, Aurora, CO 80045, USA.
  • Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA 92093, USA.
  • Benaroya Research Institute, Seattle, WA 98101, USA.
  • Division of Immunology and Rheumatology, Stanford University, Stanford, CA 94305, USA and VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Holers, V. M., Kuhn, K. A., Demoruelle, M. K., Norris, J. M., Firestein, G. S., James, E. A., Robinson, W. H., Buckner, J. H., & Deane, K. D. (2022). Mechanism‐driven strategies for prevention of rheumatoid arthritis. Rheumatology & Autoimmunity, 2(3), 109-119. https://doi.org/10.1002/rai2.12043

Vancouver

Holers VM, Kuhn KA, Demoruelle MK, Norris JM, Firestein GS, James EA, et al. Mechanism‐driven strategies for prevention of rheumatoid arthritis. Rheumatology & Autoimmunity. 2022;2(3):109-119. doi:10.1002/rai2.12043

BibTeX
@article{Holers2022,
  author = {Holers, V Michael and Kuhn, Kristine A and Demoruelle, M Kristen and Norris, Jill M and Firestein, Gary S and James, Eddie A and Robinson, William H and Buckner, Jane H and Deane, Kevin D},
  title = {Mechanism‐driven strategies for prevention of rheumatoid arthritis},
  journal = {Rheumatology & Autoimmunity},
  year = {2022},
  volume = {2},
  number = {3},
  pages = {109--119},
  doi = {10.1002/rai2.12043}
}
Kostenlos starten →